|Articles|March 1, 2020
- BioPharm International-03-01-2020
- Volume 33
- Issue 3
BioPharm International, March 2020 Issue (PDF)
Click the title above to open the BioPharm International March 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Improving Upstream Predictabilityover 5 years ago
The Future of Raw Material Sources for mAbsover 5 years ago
Building Data Quality in Generates Quality Data Outover 5 years ago
Flexible Facilities for Viral Vector Manufacturingover 5 years ago
Stability Testing: The Crucial Development Stepover 5 years ago
Navigating GMPs for Gene Therapiesover 5 years ago
The Costs of Commercializing CRISPRover 5 years ago
Seeking Early Answers to Formulation Questionsover 5 years ago
Drug Production Draws Multiple Contendersover 5 years ago
Coronavirus Response: Reaction or New Reality?Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
4
Behind the Headlines Episode 27: Unpacking Mega Deals and R&D Directions
5
